INS and cancer: Recent studies found that metformin not only effectively reduced hepatic glucose production and increased insulin sensitivity, but that it also was effective in decreasing the risk of cancer in patients with type 2 diabetes, inhibiting the growth of cancer cells and enhancing the effects of chemotherapeutic drugs (1).